Major depressive disorder, single episode, in partial remission
ICD-10 F32.4 is a billable code used to indicate a diagnosis of major depressive disorder, single episode, in partial remission.
F32.4 refers to a major depressive disorder characterized by a single episode where the patient has shown some improvement in symptoms but is not fully recovered. This condition is marked by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in daily activities. In partial remission, the individual may still experience some depressive symptoms, but these are less severe than during the acute phase of the disorder. The diagnosis requires careful assessment of the patient's mood, functional impairment, and any history of previous depressive episodes. Treatment often involves a combination of psychotherapy and pharmacotherapy, including mood stabilizers and antidepressants. Regular monitoring for suicide risk is crucial, as individuals with major depressive disorder have an elevated risk of self-harm and suicidal ideation, particularly during periods of exacerbation or when transitioning between treatment phases.
Comprehensive mental status examination, treatment history, and risk assessments.
Initial evaluation of a patient with depressive symptoms, follow-up visits to assess treatment efficacy.
Ensure thorough documentation of symptom changes and treatment adjustments.
Routine screening for depression, documentation of patient-reported outcomes.
Management of patients with known depression, monitoring for medication side effects.
Collaboration with mental health specialists for complex cases.
Used during therapy sessions for patients diagnosed with F32.4.
Document the duration of the session, treatment goals, and patient progress.
Psychiatrists should ensure that therapy notes reflect the patient's current status and treatment plan.
Partial remission indicates that the patient has experienced a reduction in depressive symptoms but still exhibits some symptoms that affect their daily functioning. This status is crucial for treatment planning and monitoring.
